Evogene Ltd (NASDAQ: EVGN)
$1.6700
+0.0700 ( +5.03% ) 37.6K
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
Market Data
Open
$1.6700
Previous close
$1.6000
Volume
37.6K
Market cap
$8.53M
Day range
$1.5010 - $1.6750
52 week range
$1.4400 - $10.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 1 | Jun 06, 2024 |
6-k | Form 6-K | 45 | May 29, 2024 |
6-k | Form 6-K | 4 | May 23, 2024 |
6-k | Form 6-K | 31 | May 23, 2024 |
6-k | Form 6-K | 6 | Apr 30, 2024 |
6-k | Form 6-K | 5 | Apr 02, 2024 |
6-k | Form 6-K | 4 | Mar 28, 2024 |
20-f | Annual reports | 122 | Mar 28, 2024 |
6-k | Form 6-K | 3 | Mar 20, 2024 |
6-k | Form 6-K | 3 | Mar 07, 2024 |